☰

Tirtha Das - Publications

Affiliations: 
2008-2019 Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Tree Info Grants Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Diaz JEL, Barcessat V, Bahamon C, Hecht C, Das TK, Cagan RL. Functional exploration of copy number alterations in a Drosophila model of triple negative breast cancer. Disease Models & Mechanisms. PMID 38721669 DOI: 10.1242/dmm.050191  0.554
2022 Dana D, Das T, Choi A, Bhuiyan AI, Das TK, Talele TT, Pathak SK. Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development. Molecules (Basel, Switzerland). 27. PMID 35056661 DOI: 10.3390/molecules27020347  0.376
2021 Xiong Z, Jeon M, Allaway RJ, Kang J, Park D, Lee J, Jeon H, Ko M, Jiang H, Zheng M, Tan AC, Guo X, Dang KK, Tropsha A, ... ... Das TK, et al. Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM Challenge. Plos Computational Biology. 17: e1009302. PMID 34520464 DOI: 10.1371/journal.pcbi.1009302  0.555
2021 Das TK, Gatto J, Mirmira R, Hourizadeh E, Kaufman D, Gelb BD, Cagan R. Drosophila RASopathy models identify disease subtype differences and biomarkers of drug efficacy. Iscience. 24: 102306. PMID 33855281 DOI: 10.1016/j.isci.2021.102306  0.53
2018 Das TK, Esernio J, Cagan R. . Cancer Research. PMID 29844121 DOI: 10.1158/0008-5472.CAN-17-2001  0.55
2018 Das TK, Cagan RL. Non-mammalian models of multiple endocrine neoplasia type 2. Endocrine-Related Cancer. 25: T91-T104. PMID 29348307 DOI: 10.1530/ERC-17-0411  0.571
2017 Das TK, Cagan RL. KIF5B-RET Oncoprotein Signals through a Multi-kinase Signaling Hub. Cell Reports. 20: 2368-2383. PMID 28877471 DOI: 10.1016/j.celrep.2017.08.037  0.553
2013 Das TK, Cagan RL. A Drosophila approach to thyroid cancer therapeutics. Drug Discovery Today. Technologies. 10: e65-71. PMID 24050232 DOI: 10.1016/j.ddtec.2012.09.004  0.57
2012 Fu S, Yang Y, Das TK, Tirtha D, Yen Y, Zhou BS, Zhou MM, Ohlmeyer M, Ko EC, Cagan R, Rosenstein BS, Chen SH, Kao J. γ-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizers. Plos One. 7: e38465. PMID 22768044 DOI: 10.1371/journal.pone.0038465  0.514
2012 Dar AC, Das TK, Shokat KM, Cagan RL. Chemical genetic discovery of targets and anti-targets for cancer polypharmacology. Nature. 486: 80-4. PMID 22678283 DOI: 10.1038/Nature11127  0.581
2012 Rudrapatna VA, Cagan RL, Das TK. Drosophila cancer models. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 241: 107-18. PMID 22038952 DOI: 10.1002/dvdy.22771  0.612
2012 Fu S, Yang Y, Das TK, Yen Y, Zhou B, Zhou M, Ohlmeyer M, Ko EC, Cagan R, Rosenstein BS, Chen S, Kao J. Correction: γ-H2AX Kinetics as a Novel Approach to High Content Screening for Small Molecule Radiosensitizers Plos One. 7. DOI: 10.1371/Annotation/0D7595F1-C719-4Ed9-Bef0-8308F4Cac7E3  0.433
2010 Das T, Cagan R. Drosophila as a novel therapeutic discovery tool for thyroid cancer. Thyroid : Official Journal of the American Thyroid Association. 20: 689-95. PMID 20578898 DOI: 10.1089/Thy.2010.1637  0.615
Show low-probability matches.